Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.554,44
0,47%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Elicio Therapeutics Inc (ELTX) Elicio Therapeutics Inc (ELTX) Notizie

ELTX

Elicio Therapeutics (ELTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELTX
DataOraFonteTitoloSimboloCompagnia
18/12/202422:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
12/12/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
12/12/202413:00GlobeNewswire Inc.Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024NASDAQ:ELTXElicio Therapeutics Inc
03/12/202413:00GlobeNewswire Inc.Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study EnrollmentNASDAQ:ELTXElicio Therapeutics Inc
22/11/202414:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELTXElicio Therapeutics Inc
21/11/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELTXElicio Therapeutics Inc
13/11/202422:21Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELTXElicio Therapeutics Inc
13/11/202422:05GlobeNewswire Inc.Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:ELTXElicio Therapeutics Inc
07/11/202422:05GlobeNewswire Inc.Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual MeetingNASDAQ:ELTXElicio Therapeutics Inc
31/10/202413:30GlobeNewswire Inc.Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation SummitNASDAQ:ELTXElicio Therapeutics Inc
16/10/202414:30GlobeNewswire Inc.Elicio Therapeutics Reports Inducement GrantsNASDAQ:ELTXElicio Therapeutics Inc
27/09/202422:42Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ELTXElicio Therapeutics Inc
27/09/202422:41Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ELTXElicio Therapeutics Inc
17/09/202422:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ELTXElicio Therapeutics Inc
13/09/202414:30GlobeNewswire Inc.Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile VaccinesNASDAQ:ELTXElicio Therapeutics Inc
28/08/202414:00GlobeNewswire Inc.Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ELTXElicio Therapeutics Inc
13/08/202422:30GlobeNewswire Inc.Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:ELTXElicio Therapeutics Inc
12/08/202422:05GlobeNewswire Inc.Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible NoteNASDAQ:ELTXElicio Therapeutics Inc
28/06/202415:00GlobeNewswire Inc.Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public OfferingNASDAQ:ELTXElicio Therapeutics Inc
27/06/202422:05GlobeNewswire Inc.Elicio Therapeutics Announces Proposed Public OfferingNASDAQ:ELTXElicio Therapeutics Inc
27/06/202422:01GlobeNewswire Inc.Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7PNASDAQ:ELTXElicio Therapeutics Inc
03/06/202422:41Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ELTXElicio Therapeutics Inc
23/05/202423:30GlobeNewswire Inc.Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual MeetingNASDAQ:ELTXElicio Therapeutics Inc
15/05/202422:30GlobeNewswire Inc.Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:ELTXElicio Therapeutics Inc
25/04/202414:30GlobeNewswire Inc.Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual MeetingNASDAQ:ELTXElicio Therapeutics Inc
05/04/202422:30GlobeNewswire Inc.Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual MeetingNASDAQ:ELTXElicio Therapeutics Inc
29/03/202413:30GlobeNewswire Inc.Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate UpdatesNASDAQ:ELTXElicio Therapeutics Inc
18/03/202413:00GlobeNewswire Inc.Elicio Therapeutics Announces $6.0 Million Private Placement FinancingNASDAQ:ELTXElicio Therapeutics Inc
05/02/202414:30GlobeNewswire Inc.Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:ELTXElicio Therapeutics Inc
25/01/202415:00GlobeNewswire Inc.Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid TumorsNASDAQ:ELTXElicio Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network